July 2nd 2024 FDA approves Shorla Oncology’s TEPYLUTE for cancer treatment https://www.pharmaceutical-technology.com/news/fda-approves-shorla-tepylute/
FDA Approves Tepylute for Breast and Ovarian Cancer TreatmentJuly 2nd 2024Read More FDA Approves Tepylute for Breast and Ovarian Cancer Treatment
Shorla Oncology Announces FDA Approval for TEPYLUTE, A Novel Formulation to Treat Breast and Ovarian CancerJuly 2nd 2024Read More Shorla Oncology Announces FDA Approval for TEPYLUTE, A Novel Formulation to Treat Breast and Ovarian Cancer
Sharon Cunningham & Orlaith Ryan are 2024 EY Entrepreneur Of The Year FinalistsApril 24th 2024Read More Sharon Cunningham & Orlaith Ryan are 2024 EY Entrepreneur Of The Year Finalists
FDA Considers SH-201 for Treating Certain Leukemias and CancersApril 22nd 2024Read More FDA Considers SH-201 for Treating Certain Leukemias and Cancers